Clinic
Srs-San Diego LLC
Srs-San Diego LLC was paid $3K by Medicaid between Sep 2024 and Sep 2024, across 1 billing code. Its largest line is J0887, Injection, epoetin beta, 1 microgram, (for esrd on dialysis) — 100% of everything it billed.
33Billing provider infoSRS-SAN DIEGO LLC
CHULA VISTA, CA 91914
CHULA VISTA, CA 91914
33aNPI1871129379assigned 03/16/2020
33bProvider typeEnd-Stage Renal Disease (ESRD) Treatment Clinic/Center
28Total paid$3K
24GClaims21
24DCodes billed1
24AFirst – last monthSep 2024 – Sep 2024
Compared with peers
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in California
Rank by total paid#723 of 728
Median peer was paid$3.91M
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2024incomplete | 21 | $3K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 100% | 21 | 12 | $3K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTANNENBAUM, JEROME (CEO)
| Provider | Location | Paid |
|---|---|---|
| SRS - Tehachapi LLC | Tehachapi, CA | $1.64M |
| Srs-Nashville HH LLC | Nashville, TN | $830K |
| Srs-Ridgecrest | Ridgecrest, CA | $156K |
| Srs-Provo, LLC | Provo, UT | $12K |
| National Tele-Nephrology Associates PC | Nashville, TN | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.